EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Primary hypertrophic osteoarthropathy complicated with myelofibrosis and compound heterozygous SLCO2A1 mutations: a case report and review of literature

Qirui Xu, Qian Li, Jin Lu, Liru Wang

Frontiers in Oncology · 30.06.2026 · 16

DOI: 10.3389/fonc.2026.1772374 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 30.06.2026. Verfasst von Qirui Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing, China. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary hypertrophic osteoarthropathy (PHO) is a rare hereditary clinical syndrome characterized by digital clubbing, periostosis, and pachydermia. It is mainly caused by mutations in SLCO2A1 or HPGD, leading to impaired degradation and elevated levels of prostaglandin E2 (PGE2). In addition to the typical skeletal and skin manifestations, some patients may present with gastrointestinal or hematologic abnormalities, including anemia and myelofibrosis. This report describes a case of PHO with myelofibrosis and compound heterozygous SLCO2A1 mutations and review the literature. Case report A 45-year-old man presented with a long history of severe fatigue and recurrent anemia accompanied by digital clubbing and skin thickening. Bone marrow biopsy revealed myelofibrosis, and imaging studies showed periostosis of the long bones. Given the anemia and gastrointestinal symptoms, differential diagnoses included Crohn’s disease, intestinal tuberculosis, and other hematologic disorders associated with myelofibrosis, which were excluded by endoscopic and hematologic evaluations. Whole-exome sequencing revealed that the patient carried compound heterozygous variants in SLCO2A1 (c.940 + 1G>A and c.440G>A/p.Trp147*), confirming the diagnosis of PHO. Family investigation showed that his parents and offspring were all asymptomatic carriers with one heterozygous variant, which is consistent with autosomal recessive inheritance.

Conclusion

Myelofibrosis is a rare but important complication of PHO and may be more frequent in patients with biallelic SLCO2A1 variants. Genetic testing and hematologic evaluation in PHO patients can help with early identification of related complications.

Schlagwörter

Stichwörter der Autor:innen

SLCO2A1biallellic variantscompound heterozygous mutationmyelofibrosisprimary hypertrophic osteoarthropathy

Autor:innen und Institutionen

  • Department of Hematology, Fu Xing Hospital, Capital Medical University, Beijing, China.
  • Peking University People's Hospital, National Clinical Research Center for Hematologic Diseases, Peking University Institute of Hematology, Beijing, China.

Zitieren

APA

Xu, Q., Li, Q., Lu, J., & Wang, L. (2026). Primary hypertrophic osteoarthropathy complicated with myelofibrosis and compound heterozygous SLCO2A1 mutations: a case report and review of literature. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1772374

Vancouver

Xu Q, Li Q, Lu J, Wang L. Primary hypertrophic osteoarthropathy complicated with myelofibrosis and compound heterozygous SLCO2A1 mutations: a case report and review of literature. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1772374

BibTeX
@article{Xu2026,
  author = {Xu, Qirui and Li, Qian and Lu, Jin and Wang, Liru},
  title = {Primary hypertrophic osteoarthropathy complicated with myelofibrosis and compound heterozygous SLCO2A1 mutations: a case report and review of literature},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1772374}
}
Kostenlos starten →